Regulus Therapeutics Inc. RGLS
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| BVF Partners OS Ltd. | Cayman Islands | 0 | 58663 | 0 | 58663 | 58663 | 0 % | 14/11/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 448946 | 0 | 448946 | 448946 | 0 % | 14/11/2024 |
| BVF Inc. | Delaware | 0 | 883844 | 0 | 883844 | 883844 | 1.3 % | 14/11/2024 |
| BVF I GP LLC | Delaware | 0 | 448946 | 0 | 448946 | 448946 | 0 % | 14/11/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 359294 | 0 | 359294 | 359294 | 0 % | 14/11/2024 |
| BVF II GP LLC | Delaware | 0 | 359294 | 0 | 359294 | 359294 | 0 % | 14/11/2024 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 58663 | 0 | 58663 | 58663 | 0 % | 14/11/2024 |
| BVF Partners L.P. | Delaware | 0 | 883844 | 0 | 883844 | 883844 | 1.3 % | 14/11/2024 |
| Mark N. Lampert | United States | 0 | 883844 | 0 | 883844 | 883844 | 1.3 % | 14/11/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 808240 | 0 | 808240 | 808240 | 1.2 % | 14/11/2024 |
| BlackRock, Inc. | Delaware | 4036126 | 0 | 4081038 | 0 | 4081038 | 6.2 % | 08/11/2024 |
| BlackRock, Inc. | Delaware | 0 | 0 | 4081038 | 0 | 4081038 | 6.2 % | 24/10/2024 |
| Ting Jia | China | 0 | 4263701 | 0 | 4263701 | 4263701 | 6.5 % | 11/10/2024 |
| Octagon Private Opportunities Fund II LP | Delaware | 0 | 2187500 | 0 | 2187500 | 2187500 | 3.3 % | 11/10/2024 |
| Octagon Capital Advisors LP | Delaware | 0 | 4263701 | 0 | 4263701 | 4263701 | 6.5 % | 11/10/2024 |
| Octagon Investments Master Fund LP | Cayman Islands | 0 | 2076201 | 0 | 2076201 | 2076201 | 3.2 % | 11/10/2024 |
| DAFNA Capital Management, LLC | Delaware | 1111049 | 0 | 1111049 | 0 | 1111049 | 5.49 % | 14/02/2024 |
| Nathan Fischel | Austria citizen (U.S. permanent resident) | 1111049 | 0 | 1111049 | 0 | 1111049 | 5.49 % | 14/02/2024 |
| Fariba Ghodsian | United States of America | 1111049 | 0 | 1111049 | 0 | 1111049 | 5.49 % | 14/02/2024 |
| FMR LLC | Delaware | 2922600 | 0 | 2922600 | 0 | 2922600 | 14.452 % | 09/02/2024 |
| Abigail P. Johnson | United States of America | 0 | 0 | 2922600 | 0 | 2922600 | 14.452 % | 09/02/2024 |
| Victory Capital Management Inc. | New York | 1155516 | 0 | 1155516 | 0 | 1155516 | 5.71 % | 06/02/2024 |
| Federated Hermes, Inc. | Pennsylvania | 4023860 | 4023860 | 4023860 | 19.9 % | 18/01/2024 | ||
| Ann C. Donahue | United States | 4023860 | 4023860 | 4023860 | 19.9 % | 18/01/2024 | ||
| J. Christopher Donahue | United States | 4023860 | 4023860 | 4023860 | 19.9 % | 18/01/2024 | ||
| Thomas R. Donahue | United States | 4023860 | 4023860 | 4023860 | 19.9 % | 18/01/2024 | ||
| Voting Shares Irrevocable Trust | Pennsylvania | 4023860 | 4023860 | 4023860 | 19.9 % | 18/01/2024 | ||
| Voting Shares Irrevocable Trust | Pennsylvania | 3875578 | 0 | 3875578 | 0 | 3875578 | 19.9 % | 10/05/2023 |
| J. Christopher Donahue | United States | 0 | 3875578 | 0 | 3875578 | 3875578 | 19.9 % | 10/05/2023 |
| Federated Hermes, Inc. | Pennsylvania | 3875578 | 0 | 3875578 | 0 | 3875578 | 19.9 % | 10/05/2023 |
| Thomas R. Donahue | United States | 0 | 3875578 | 0 | 3875578 | 3875578 | 19.9 % | 10/05/2023 |
| Ann C. Donahue | United States | 0 | 3875578 | 0 | 3875578 | 3875578 | 19.9 % | 10/05/2023 |
| Victory Capital Management Inc. | New York | 0 | 850197 | 0 | 850197 | 5.05 % | 31/01/2023 | |
| Abigail P. Johnson | United States of America | 0 | 0 | 2195000 | 0 | 2195000 | 14.998 % | 11/10/2022 |
| FMR LLC | Delaware | 2195000 | 0 | 2195000 | 0 | 2195000 | 14.998 % | 11/10/2022 |
| Abigail P. Johnson | United States of America | 0 | 0 | 2195000 | 0 | 2195000 | 14.998 % | 11/10/2022 |
| FMR LLC | Delaware | 2195000 | 0 | 2195000 | 0 | 2195000 | 14.998 % | 11/10/2022 |
| Thomas R. Donahue | 29048265 | 29048265 | 29048265 | 19.9 % | 16/05/2022 | |||
| Rhodora J. Donahue | 29048265 | 29048265 | 29048265 | 19.9 % | 16/05/2022 | |||
| J. Christopher Donahue | 29048265 | 29048265 | 29048265 | 19.9 % | 16/05/2022 | |||
| (entities only Federated Hermes, Inc. | 29048265 | 29048265 | 29048265 | 19.9 % | 16/05/2022 | |||
| Voting Shares Irrevocable Trust | 29048265 | 29048265 | 29048265 | 19.9 % | 16/05/2022 | |||
| Victory Capital Management Inc. | New York | 0 | 8503643 | 0 | 8503643 | 5.83 % | 02/02/2022 | |
| Victory Capital Management Inc. | New York | 0 | 8503642 | 0 | 8503642 | 5.83 % | 04/01/2022 | |
| Victory Capital Management Inc. | New York | 0 | 8519242 | 0 | 8519242 | 12.73 % | 08/03/2021 | |
| Steven A. Cohen | United States | 0 | 5627013 | 0 | 5627013 | 5627013 | 8.5 % | 09/12/2020 |
| Point72 Asset Management, L.P. | Delaware | 0 | 5627013 | 0 | 5627013 | 5627013 | 8.5 % | 09/12/2020 |
| Point72 Capital Advisors, Inc. | Delaware | 0 | 5627013 | 0 | 5627013 | 5627013 | 8.5 % | 09/12/2020 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 2322644 | 0 | 2322644 | 2322644 | 9.99 % | 03/01/2020 |
| EcoR1 Capital, LLC | Delaware | 0 | 2322644 | 0 | 2322644 | 2322644 | 9.99 % | 03/01/2020 |
| Oleg Nodelman | United States | 0 | 2322644 | 0 | 2322644 | 2322644 | 9.99 % | 03/01/2020 |
| EIN | Delaware, United States of America | 1327801 | 0 | 1327801 | 1327801 | 9.99 % | 31/12/2019 | |
| EIN | Delaware, United States of America | 1327801 | 0 | 1327801 | 1327801 | 9.99 % | 17/05/2019 | |
| Abigail P. Johnson | United States of America | 0 | 0 | 0 | 0 | 0 | 0 % | 10/12/2018 |
| FMR LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 10/12/2018 |
| Abigail P. Johnson | United States of America | 0 | 0 | 8537762 | 0 | 8537762 | 8.184 % | 10/08/2018 |
| FMR LLC | Delaware | 1550357 | 0 | 8537762 | 0 | 8537762 | 8.184 % | 10/08/2018 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 14/02/2018 |
| Oleg Nodelman | United States | 0 | 0 | 0 | 0 | 0 | 0 % | 14/02/2018 |
| EcoR1 Capital, LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 14/02/2018 |
| Alnylam Pharmaceuticals, Inc. | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 09/08/2017 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 953985 | 0 | 953985 | 953985 | 0 % | 24/07/2017 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 5324479 | 0 | 5324479 | 5324479 | 5.5 % | 24/07/2017 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 3430051 | 0 | 3430051 | 3430051 | 3.5 % | 24/07/2017 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 953985 | 0 | 953985 | 953985 | 0 % | 24/07/2017 |
| BVF Partners L.P. | Delaware | 0 | 12949229 | 0 | 12949229 | 12949229 | 13.3 % | 24/07/2017 |
| BVF Inc. | Delaware | 0 | 12949229 | 0 | 12949229 | 12949229 | 13.3 % | 24/07/2017 |
| Mark N. Lampert | United States | 0 | 12949229 | 0 | 12949229 | 12949229 | 13.3 % | 24/07/2017 |
| Broadfin Capital, LLC | Delaware | 0 | 5494505 | 0 | 5494505 | 5494505 | 5.65 % | 24/07/2017 |
| Broadfin Healthcare Master Fund, Ltd. | Cayman Islands | 0 | 5494505 | 0 | 5494505 | 5494505 | 5.65 % | 24/07/2017 |
| Kevin Kotler | United States of America | 0 | 5494505 | 0 | 5494505 | 5494505 | 5.65 % | 24/07/2017 |
| EcoR1 Capital, LLC | Delaware | 0 | 5117144 | 0 | 5117144 | 5117144 | 9.6 % | 30/05/2017 |
| Oleg Nodelman | United States | 0 | 5117144 | 0 | 5117144 | 5117144 | 9.6 % | 30/05/2017 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 3958597 | 0 | 3958597 | 3958597 | 7.4 % | 30/05/2017 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1507731 | 0 | 1507731 | 1507731 | 2.8 % | 05/05/2017 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 987526 | 0 | 987526 | 987526 | 1.9 % | 05/05/2017 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 272433 | 0 | 272433 | 272433 | 0 % | 05/05/2017 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 272433 | 0 | 272433 | 272433 | 0 % | 05/05/2017 |
| BVF Partners L.P. | Delaware | 0 | 3278900 | 0 | 3278900 | 3278900 | 6.2 % | 05/05/2017 |
| BVF Inc. | Delaware | 0 | 3278900 | 0 | 3278900 | 3278900 | 6.2 % | 05/05/2017 |
| Mark N. Lampert | United States | 0 | 3278900 | 0 | 3278900 | 3278900 | 6.2 % | 05/05/2017 |
| Wellington Management Group LLP | Massachusetts | 0 | 0 | 0 | 0 | 0 | 0 % | 10/04/2017 |
| Wellington Investment Advisors Holdings LLP | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 10/04/2017 |
| Wellington Group Holdings LLP | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 10/04/2017 |
| Fidelity Growth Company Fund | Massachusetts | 2964145 | 0 | 0 | 0 | 2964145 | 5.6 % | 14/02/2017 |
| FMR LLC | Delaware | 1460648 | 0 | 7938495 | 0 | 7938495 | 14.999 % | 14/02/2017 |
| Abigail P. Johnson | United States of America | 0 | 0 | 7938495 | 0 | 7938495 | 14.999 % | 14/02/2017 |
| Alnylam Pharmaceuticals, Inc. | Delaware | 3998621 | 0 | 3998621 | 0 | 3998621 | 7.6 % | 13/02/2017 |
| and | Switzerland | 0 | 0 | 0 | 0 | 0 | 0 % | 20/01/2017 |
| RA Capital Management, LLC | Massachusetts | 0 | 3482924 | 0 | 3482924 | 3482924 | 6.7 % | 16/02/2016 |
| Peter Kolchinsky | United States | 0 | 3482924 | 0 | 3482924 | 3482924 | 6.7 % | 16/02/2016 |
| RA Capital Healthcare Fund, L.P. | Delaware | 0 | 2877679 | 0 | 2877679 | 2877679 | 5.5 % | 16/02/2016 |
| and | Switzerland | 2609098 | 0 | 0 | 2841243 | 2841243 | 5.43 % | 16/02/2016 |
| Foresite Capital Management II, LLC | Delaware | 1859717 | 5 | 1859717 | 0 | 1859717 | 3.6 % | 05/02/2016 |
| Foresite Capital Fund III, L.P. | Delaware | 789091 | 5 | 789091 | 0 | 789091 | 1.5 % | 05/02/2016 |
| Foresite Capital Management III, LLC | Delaware | 789091 | 5 | 789091 | 0 | 789091 | 1.5 % | 05/02/2016 |
| James Tananbaum | United States | 2648808 | 5 | 2648808 | 0 | 2648808 | 5.1 % | 05/02/2016 |
| Foresite Capital Fund II, L.P. | Delaware | 1859717 | 5 | 1859717 | 0 | 1859717 | 3.6 % | 05/02/2016 |
| Foresite Capital Management II, LLC | Delaware | 1750669 | 1750669 | 1750669 | 1750669 | 1750669 | 3.3 % | 05/02/2016 |
| Foresite Capital Fund II, L.P. | Delaware | 1750669 | 1750669 | 1750669 | 1750669 | 1750669 | 3.3 % | 05/02/2016 |
| Foresite Capital Management III, LLC | Delaware | 718997 | 718997 | 718997 | 718997 | 718997 | 1.4 % | 05/02/2016 |
| James Tananbaum | United States | 2469666 | 2469666 | 2469666 | 2469666 | 2469666 | 4.7 % | 05/02/2016 |
| Foresite Capital Fund III, L.P. | Delaware | 718997 | 718997 | 718997 | 718997 | 718997 | 1.4 % | 05/02/2016 |
| James Tananbaum | United States | 2729971 | 2729971 | 2729971 | 2729971 | 2729971 | 5.26 % | 08/09/2015 |
| Foresite Capital Fund II, L.P. | Delaware | 2000269 | 2000269 | 2000269 | 2000269 | 2000269 | 3.85 % | 08/09/2015 |
| Foresite Capital Management II, LLC | Delaware | 2000269 | 2000269 | 2000269 | 2000269 | 2000269 | 3.85 % | 08/09/2015 |
| Foresite Capital Fund III, L.P. | Delaware | 729702 | 729702 | 729702 | 729702 | 729702 | 1.41 % | 08/09/2015 |
| Foresite Capital Management III, LLC | Delaware | 729702 | 729702 | 729702 | 729702 | 729702 | 1.41 % | 08/09/2015 |
| Wellington Management Company LLP | Delaware | 0 | 4799733 | 0 | 5122726 | 5122726 | 10.14 % | 10/04/2015 |
| Wellington Investment Advisors Holdings LLP | Delaware | 0 | 4902388 | 0 | 5410597 | 5410597 | 10.71 % | 10/04/2015 |
| Wellington Group Holdings LLP | Delaware | 0 | 4902388 | 0 | 5410597 | 5410597 | 10.71 % | 10/04/2015 |
| Wellington Management Group LLP | Massachusetts | 0 | 4902388 | 0 | 5410597 | 5410597 | 10.71 % | 10/04/2015 |
| RA Capital Management, LLC | Massachusetts | 0 | 4742911 | 0 | 4742911 | 4742911 | 9.8 % | 17/02/2015 |
| Peter Kolchinsky | United States | 0 | 4742911 | 0 | 4742911 | 4742911 | 9.8 % | 17/02/2015 |
| RA Capital Healthcare Fund, L.P. | Delaware | 0 | 3889278 | 0 | 3889278 | 3889278 | 8 % | 17/02/2015 |
| RA Capital Management, LLC | Massachusetts | 0 | 4742911 | 0 | 4742911 | 4742911 | 9.8 % | 07/11/2014 |
| Peter Kolchinsky | United States | 0 | 4742911 | 0 | 4742911 | 4742911 | 9.8 % | 07/11/2014 |
| RA Capital Healthcare Fund, L.P. | Delaware | 0 | 3889278 | 0 | 3889278 | 3889278 | 8 % | 07/11/2014 |
| Sanofi | 5 | 11.73 % | 05/02/2014 | |||||
| FMR LLC | Delaware | 0 | 0 | 3909452 | 0 | 3909452 | 10.857 % | 10/07/2013 |
| Edward C. Johnson 3d | United States of America | 0 | 0 | 3909452 | 0 | 3909452 | 10.857 % | 10/07/2013 |
| I.R.S. Identification Nos. of above persons (entities only). | Delaware | 6150500 | 0 | 6150500 | 0 | 6150500 | 17.2 % | 14/02/2013 |
| BVF Inc. | Delaware | 0 | 3000000 | 0 | 3000000 | 3000000 | 8.8 % | 15/10/2012 |
| Mark N. Lampert | United States | 0 | 3000000 | 0 | 3000000 | 3000000 | 8.8 % | 15/10/2012 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 1097439 | 0 | 1097439 | 1097439 | 3.2 % | 15/10/2012 |
| BVF Partners L.P. | Delaware | 0 | 3000000 | 0 | 3000000 | 3000000 | 8.8 % | 15/10/2012 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1902561 | 0 | 1902561 | 1902561 | 5.6 % | 15/10/2012 |
| GlaxoSmithKline plc | England and Wales | 3303775 | 0 | 3303775 | 0 | 3303775 | 9.3 % | 10/10/2012 |
| Sanofi | The Republic of France | 3749999 | 0 | 0 | 3749999 | 3749999 | 10.99 % | 09/10/2012 |